AstraZeneca and Par Pharmaceutical have signed an agreement for Par to distribute an authorized generic version of AstraZeneca's Toporol (metoprolol succinate) in the U.S. Authorized generics represent branded pharma's response to the fierce competition they're facing from generic drug companies as a number of blockbuster drugs lose patent protection. Release